TCIM
MDCO

TIAA CREF Investment Management’s Medicines Co MDCO Stock Holding History

TIAA CREF Investment Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$3.74M Sell
133,798
-33,857
-20% -$798K ﹤0.01% 1626
2018
Q4 		$3.21M Buy
167,655
+24,858
+17% +$578K ﹤0.01% 1661
2018
Q3 		$4.27M Sell
142,797
-20,791
-13% -$783K ﹤0.01% 1668
2018
Q2 		$6M Sell
163,588
-13,564
-8% -$441K ﹤0.01% 1474
2018
Q1 		$5.83M Sell
177,152
-2,306
-1% -$72.1K ﹤0.01% 1461
2017
Q4 		$4.91M Sell
179,458
-1,032
-0.6% -$31.8K ﹤0.01% 1609
2017
Q3 		$6.68M Sell
180,490
-5,739
-3% -$212K ﹤0.01% 1442
2017
Q2 		$7.08M Sell
186,229
-1,501
-0.8% -$66.8K 0.01% 1353
2017
Q1 		$9.18M Sell
187,730
-14,768
-7% -$674K 0.01% 1175
2016
Q4 		$6.87M Sell
202,498
-17,293
-8% -$613K 0.01% 1389
2016
Q3 		$8.29K Sell
219,791
-1,686
-0.8% -$63.5K 0.01% 1246
2016
Q2 		$7.45M Sell
221,477
-48,639
-18% -$1.71M 0.01% 1257
2016
Q1 		$8.58M Sell
270,116
-19,176
-7% -$626K 0.01% 1137
2015
Q4 		$10.8M Sell
289,292
-30,929
-10% -$1.17M 0.01% 1025
2015
Q3 		$12.2M Buy
320,221
+20,033
+7% +$703K 0.01% 945
2015
Q2 		$8.59M Sell
300,188
-2,308
-0.8% -$64.3K 0.01% 1261
2015
Q1 		$8.48M Sell
302,496
-4,086
-1% -$115K 0.01% 1273
2014
Q4 		$8.48M Sell
306,582
-12,909
-4% -$320K 0.01% 1238
2014
Q3 		$7.13M Sell
319,491
-7,110
-2% -$181K 0.01% 1342
2014
Q2 		$9.49M Buy
326,601
+5,310
+2% +$142K 0.01% 1195
2014
Q1 		$9.13M Sell
321,291
-4,680
-1% -$155K 0.01% 1192
2013
Q4 		$12.6M Buy
325,971
+8,245
+3% +$295K 0.01% 1021
2013
Q3 		$10.7M Buy
317,726
+13,581
+4% +$433K 0.01% 1053
2013
Q2 		$9.36M Buy
+304,145
New +$10.2M 0.01% 1090

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

TIAA CREF Investment Management's MDCO Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Medicines Co (MDCO) stake by 20% in Q1 2019, selling an estimated $798K and leaving 133,798 shares worth $3.74M. The position accounts for ﹤0.01% of the portfolio, ranked #1626.

TIAA CREF Investment Management first reported a position in MDCO in Q2 2013 and has held it in 24 quarters since. The position peaked at $12.6M in Q4 2013. 203 funds tracked by Wall St. Rank hold MDCO as of Q1 2019.

  • TIAA CREF Investment Management held 133,798 shares of Medicines Co worth $3.74M as of Q1 2019.
  • TIAA CREF Investment Management sold 33,857 Medicines Co shares in Q1 2019, an estimated $798K.
  • Medicines Co made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1626 holding.
  • TIAA CREF Investment Management first reported a position in Medicines Co in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Medicines Co position peaked at $12.6M in Q4 2013.
  • 203 funds tracked by Wall St. Rank held Medicines Co as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.